Maintenance oral viscous budesonide reduces dilation recurrence after esophageal atresia repair: a prospective clinical study - Scorecard - MDSpire

Maintenance oral viscous budesonide reduces dilation recurrence after esophageal atresia repair: a prospective clinical study

  • By

  • Cosimo Ruggiero

  • Giusy Russo

  • Denis Cozzi

  • Danila Volpe

  • Silvia Ceccanti

  • Paola Papoff

  • Miriam D’Orsi

  • Tonia Raso

  • Giulia Mancuso

  • Salvatore Oliva

  • May 14, 2026

  • 0 min

Share

Clinical Scorecard: Oral Viscous Budesonide for Maintenance Therapy Decreases Recurrence of Dilation Following Esophageal Atresia Surgery: Findings from a Prospective Clinical Trial

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationChildren aged 2–18 years with repaired esophageal atresia and steroid-responsive recurrent anastomotic stricture.
Care Setting

Key Highlights

  • dysphagia_scores

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • I
      • n
      • c
      • l
      • u
      • d
      • e
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • f
      • o
      • l
      • l
      • o
      • w
      • -
      • u
      • p
      • i
      • n
      • t
      • e
      • r
      • v
      • a
      • l
      • s
      • f
      • o
      • r
      • d
      • y
      • s
      • p
      • h
      • a
      • g
      • i
      • a
      • a
      • n
      • d
      • s
      • t
      • r
      • i
      • c
      • t
      • u
      • r
      • e
      • r
      • e
      • c
      • u
      • r
      • r
      • e
      • n
      • c
      • e
      • .

      Risks

        Patient & Prescribing Data

        Add rationale for dosage differences.

        Clinical Best Practices

        • best_practices

        Related Resources & Content

        Original Source(s)

        Related Content